EXEL Competitors & Alternatives
Compare Exelixis Inc with similar stocks in the same industry
Biotechnology
EXEL
Main Stock$56.04
Tradestie Score
68
Market Cap
$11.09B
P/E Ratio
18.7
Revenue Growth
0.1%
Analyst Upside
-10.1%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
INCY
Incyte Genomics Inc
|
$114.23
|
$16.93B | 16.5 | 57 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$56.45
|
$15.70B | 29.7 | 58 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.30
|
$15.22B | - | 53 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$174.10
|
$13.59B | 27.2 | 67 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$265.22
|
$12.36B | 31.3 | 61 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$34.51
|
$10.76B | - | 67 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$67.01
|
$10.74B | - | 57 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$59.20
|
$10.53B | 42.5 | 66 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$56.75
|
$10.49B | - | 44 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$83.08
|
$10.22B | - | 67 | Compare |
More EXEL Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry